{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:51:01Z","timestamp":1792785061599,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","id":[{"id":"https:\/\/ror.org\/001w7jn25","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Familial Parkinson\u2019s disease (PD) and vascular parkinsonism (VP) present overlapping features and may co-exist. To investigate whether PD and VP may share a potential pathogenic link and to what extent white matter hyperintensities may influence PD phenotype, we used the modified Scheltens scale and presented a descriptive and exploratory analysis of the classic neuroradiological features of cerebral small vessel disease (cSVD) in the axial T2-FLAIR MRI sequences in a cohort of 104 familial PD and PD prodromal patients and 48 age-matched controls from the PPMI publicly available database. We next performed whole exome sequencing to examine the protein coding variability in the main PD-causing and risk genes (\n                    <jats:italic>VPS35<\/jats:italic>\n                    ,\n                    <jats:italic>DJ1<\/jats:italic>\n                    ,\n                    <jats:italic>PINK1<\/jats:italic>\n                    ,\n                    <jats:italic>ATP13A2<\/jats:italic>\n                    ,\n                    <jats:italic>PRKN<\/jats:italic>\n                    ,\n                    <jats:italic>SNCA<\/jats:italic>\n                    ,\n                    <jats:italic>LRRK2<\/jats:italic>\n                    ,\n                    <jats:italic>GBA<\/jats:italic>\n                    ,\n                    <jats:italic>MAPT<\/jats:italic>\n                    ,\n                    <jats:italic>LAMP3<\/jats:italic>\n                    ,\n                    <jats:italic>STK39<\/jats:italic>\n                    ) in a cohort of 96 patients with familial cSVD and 243 elderly healthy individuals (HEX database). In this cohort, patients with familial and prodromal PD present a moderate burden of superficial frontal white matter hyperintensities (p-value\u2009=\u20093.46e-06, Bonferroni-corrected), linked to a mild reduction of motor and cognitive function and an increased\n                    <jats:italic>LRRK2<\/jats:italic>\n                    p.G2019S and p.R1441C variant penetrance, and bilateral basal ganglia periventricular enlarged spaces (p-value\u2009=\u20092.64e-03, Bonferroni-corrected). Moreover, one-third of familial PD patients displayed a burden of lacunar thalamic strokes (p-value\u2009=\u20090.058), associated with a moderate hypokinetic-rigid syndrome. Finally, we report no known pathogenic coding variant in the main PD causative genes and risk factors in a cohort of 96 early-onset cSVD Caucasian patients. Our study adds to the understanding of potential cSVD hallmarks within this familial\n                    <jats:italic>LRRK2<\/jats:italic>\n                    ,\n                    <jats:italic>GBA<\/jats:italic>\n                    and\n                    <jats:italic>SNCA<\/jats:italic>\n                    PD-PD prodromal cohort.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-69989-z","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T01:42:37Z","timestamp":1788831757000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring cerebral small vessel disease signatures in familial Parkinson\u2019s disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Bigyan","family":"Mahat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bimala","family":"Malla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Foddis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Beule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Bras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Guerreiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasilis","family":"Kola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Michael","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Endres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2837-1765","authenticated-orcid":false,"given":"Celeste","family":"Sassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"69989_CR1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/mds.22937","volume":"25","author":"S Kalra","year":"2010","unstructured":"Kalra, S., Grosset, D. G. & Benamer, H. T. Differentiating vascular parkinsonism from idiopathic Parkinson\u2019s disease: a systematic review. Mov. Disord. 25, 149\u2013156 (2010).","journal-title":"Mov. Disord"},{"key":"69989_CR2","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s00702-004-0192-1","volume":"111","author":"C Peralta","year":"2004","unstructured":"Peralta, C. et al. Parkinsonism following striatal infarcts: incidence in a prospective stroke unit cohort. J. Neural Transm (Vienna). 111, 1473\u20131483 (2004).","journal-title":"J. Neural Transm (Vienna)"},{"key":"69989_CR3","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1161\/STROKEAHA.112.657130","volume":"43","author":"KF de Laat","year":"2012","unstructured":"de Laat, K. F. et al. Cerebral white matter lesions and lacunar infarcts contribute to the presence of mild parkinsonian signs. Stroke 43, 2574\u20132579 (2012).","journal-title":"Stroke"},{"key":"69989_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nrneurol.2011.21","volume":"7","author":"NI Bohnen","year":"2011","unstructured":"Bohnen, N. I. & Albin, R. L. White matter lesions in Parkinson disease. Nat. Rev. Neurol. 7, 229\u2013236 (2011).","journal-title":"Nat. Rev. Neurol."},{"key":"69989_CR5","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.3174\/ajnr.A1556","volume":"30","author":"G Gattellaro","year":"2009","unstructured":"Gattellaro, G. et al. White matter involvement in idiopathic Parkinson disease: a diffusion tensor imaging study. AJNR Am. J. Neuroradiol. 30, 1222\u20131226 (2009).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"69989_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000510387","volume":"20","author":"B Ning","year":"2020","unstructured":"Ning, B. et al. Mutant G2019S-LRRK2 Induces Abnormalities in Arteriolar Cerebral Blood Volume in Mouse Brains: An MRI Study. Neurodegener Dis. 20, 65\u201372 (2020).","journal-title":"Neurodegener Dis."},{"key":"69989_CR7","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.parkreldis.2012.03.017","volume":"18","author":"A Antonini","year":"2012","unstructured":"Antonini, A. et al. The relationship between cerebral vascular disease and parkinsonism: The VADO study. Parkinsonism Relat. Disord. 18, 775\u2013780 (2012).","journal-title":"Parkinsonism Relat. Disord."},{"key":"69989_CR8","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2214\/ajr.149.2.351","volume":"149","author":"F Fazekas","year":"1987","unstructured":"Fazekas, F., Chawluk, J. B., Alavi, A., Hurtig, H. I. & Zimmerman, R. A. MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging. AJR Am. J. Roentgenol. 149, 351\u2013356 (1987).","journal-title":"AJR Am. J. Roentgenol."},{"key":"69989_CR9","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S1474-4422(19)30079-1","volume":"18","author":"JM Wardlaw","year":"2019","unstructured":"Wardlaw, J. M., Smith, C. & Dichgans, M. Small vessel disease: mechanisms and clinical implications. Lancet Neurol. 18, 684\u2013696 (2019).","journal-title":"Lancet Neurol."},{"key":"69989_CR10","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1002\/acn3.644","volume":"5","author":"K Marek","year":"2018","unstructured":"Marek, K. et al. The Parkinson\u2019s progression markers initiative (PPMI) \u2013 establishing a PD biomarker cohort. Ann. Clin. Transl Neurol. 5, 1460\u20131477 (2018).","journal-title":"Ann. Clin. Transl Neurol."},{"key":"69989_CR11","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","volume":"95","author":"Parkinson Progression Marker Initiative","year":"2011","unstructured":"Parkinson Progression Marker Initiative. The Parkinson Progression Marker Initiative (PPMI). Prog Neurobiol. 95, 629\u2013635 (2011).","journal-title":"Prog Neurobiol."},{"key":"69989_CR12","doi-asserted-by":"publisher","first-page":"1232387","DOI":"10.3389\/fnagi.2023.1232387","volume":"15","author":"H Jackson","year":"2023","unstructured":"Jackson, H. et al. Identifying prodromal symptoms at high specificity for Parkinson\u2019s disease. Front. Aging Neurosci. 15, 1232387 (2023).","journal-title":"Front. Aging Neurosci."},{"key":"69989_CR13","doi-asserted-by":"crossref","unstructured":"Singleton, A. B., Hardy, J. A. & Gasser, T. The Birth of the Modern Era of Parkinson\u2019s Disease Genetics. J Parkinsons Dis 7, S87\u2013S93 .","DOI":"10.3233\/JPD-179009"},{"key":"69989_CR14","doi-asserted-by":"publisher","first-page":"38","DOI":"10.5603\/pjnns.97806","volume":"58","author":"J Dulski","year":"2024","unstructured":"Dulski, J., Ross, O. A. & Wszolek, Z. K. Genetics of Parkinson\u2019s Disease: state-of-the-art and role in clinical settings. Neurol. Neurochir. Pol. 58, 38\u201346 (2024).","journal-title":"Neurol. Neurochir. Pol."},{"key":"69989_CR15","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/brain\/awz350","volume":"143","author":"C Blauwendraat","year":"2020","unstructured":"Blauwendraat, C. et al. Genetic modifiers of risk and age at onset in GBA associated Parkinson\u2019s disease and Lewy body dementia. Brain 143, 234\u2013248 (2020).","journal-title":"Brain"},{"key":"69989_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3233\/JPD-130192","volume":"3","author":"C Pais\u00e1n-Ruiz","year":"2013","unstructured":"Pais\u00e1n-Ruiz, C., Lewis, P. A. & Singleton, A. B. LRRK2: Cause, Risk, and Mechanism. J. Parkinsons Dis. 3, 85\u2013103 (2013).","journal-title":"J. Parkinsons Dis."},{"key":"69989_CR17","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1212\/01.wnl.0000304044.22253.03","volume":"70","author":"K Haugarvoll","year":"2008","unstructured":"Haugarvoll, K. et al. Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease. Neurology 70, 1456\u20131460 (2008).","journal-title":"Neurology"},{"key":"69989_CR18","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/mdc3.12410","volume":"4","author":"L Lalvay","year":"2017","unstructured":"Lalvay, L. et al. Quantitative Measurement of Akinesia in Parkinson\u2019s Disease. Mov. Disord Clin. Pract. 4, 316\u2013322 (2017).","journal-title":"Mov. Disord Clin. Pract."},{"key":"69989_CR19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol. Aging. 24, 197\u2013211 (2003).","journal-title":"Neurobiol. Aging"},{"key":"69989_CR20","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1177\/1533317517725811","volume":"32","author":"E Yamamoto","year":"2017","unstructured":"Yamamoto, E., Mourany, L., Colleran, R., Whitman, C. & Tousi, B. Utility of Montreal Cognitive Assessment in Differentiating Dementia With Lewy Bodies From Alzheimer\u2019s Dementia. Am. J. Alzheimers Dis. Other Demen. 32, 468\u2013471 (2017).","journal-title":"Am. J. Alzheimers Dis. Other Demen"},{"key":"69989_CR21","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/j.1532-5415.1999.tb02571.x","volume":"47","author":"A Lim","year":"1999","unstructured":"Lim, A. et al. Clinico-neuropathological correlation of Alzheimer\u2019s disease in a community-based case series. J. Am. Geriatr. Soc. 47, 564\u2013569 (1999).","journal-title":"J. Am. Geriatr. Soc."},{"key":"69989_CR22","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1001\/jama.292.23.2901","volume":"292","author":"KM Langa","year":"2004","unstructured":"Langa, K. M., Foster, N. L. & Larson, E. B. Mixed dementia: emerging concepts and therapeutic implications. JAMA 292, 2901\u20132908 (2004).","journal-title":"JAMA"},{"key":"69989_CR23","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.3389\/fneur.2019.01329","volume":"10","author":"JC Blair","year":"2019","unstructured":"Blair, J. C. et al. Brain MRI Reveals Ascending Atrophy in Parkinson\u2019s Disease Across Severity. Front. Neurol. 10, 1329 (2019).","journal-title":"Front. Neurol."},{"key":"69989_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0022-510X(93)90041-V","volume":"114","author":"P Scheltens","year":"1993","unstructured":"Scheltens, P. et al. A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J. Neurol. Sci. 114, 7\u201312 (1993).","journal-title":"J. Neurol. Sci."},{"key":"69989_CR25","doi-asserted-by":"publisher","unstructured":"Wang, S. et al. Superficial white matter microstructure affects processing speed in cerebral small vessel disease. https:\/\/doi.org\/10.1101\/2021.12.30.474604 (2022).","DOI":"10.1101\/2021.12.30.474604"},{"key":"69989_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0022-510X(90)90180-U","volume":"98","author":"I Ferrer","year":"1990","unstructured":"Ferrer, I., Bella, R., Serrano, M. T., Mart\u00ed, E. & Guionnet, N. Arteriolosclerotic leucoencephalopathy in the elderly and its relation to white matter lesions in Binswanger\u2019s disease, multi-infarct encephalopathy and Alzheimer\u2019s disease. J. Neurol. Sci. 98, 37\u201350 (1990).","journal-title":"J. Neurol. Sci."},{"key":"69989_CR27","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1161\/STROKEAHA.118.022280","volume":"49","author":"L Xiong","year":"2018","unstructured":"Xiong, L. et al. Cerebral Cortical Microinfarcts on Magnetic Resonance Imaging and Their Association With Cognition in Cerebral Amyloid Angiopathy. Stroke 49, 2330\u20132336 (2018).","journal-title":"Stroke"},{"key":"69989_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/jcbfm.2015.88","volume":"36","author":"YD Reijmer","year":"2016","unstructured":"Reijmer, Y. D., van Veluw, S. J. & Greenberg, S. M. Ischemic brain injury in cerebral amyloid angiopathy. J. Cereb. Blood Flow. Metab. 36, 40\u201354 (2016).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"69989_CR29","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1159\/000446770","volume":"6","author":"W Reginold","year":"2016","unstructured":"Reginold, W. et al. Altered Superficial White Matter on Tractography MRI in Alzheimer\u2019s Disease. Dement. Geriatr. Cogn. Dis. Extra. 6, 233\u2013241 (2016).","journal-title":"Dement. Geriatr. Cogn. Dis. Extra"},{"key":"69989_CR30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0303-8467(80)90035-9","volume":"82","author":"J de Reuck","year":"1980","unstructured":"de Reuck, J., Sieben, G. & de Coster, W. vander Ecken, H. Parkinsonism in patients with cerebral infarcts. Clin. Neurol. Neurosurg. 82, 177\u2013185 (1980).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"69989_CR31","first-page":"3","volume":"141","author":"J Poirier","year":"1985","unstructured":"Poirier, J. & Derouesn\u00e9, C. [The concept of cerebral lacunae from 1838 to the present]. Rev. Neurol. (Paris). 141, 3\u201317 (1985).","journal-title":"Rev. Neurol. (Paris)"},{"key":"69989_CR32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/ijs.12543","volume":"10 Suppl A100","author":"I Riba-Llena","year":"2015","unstructured":"Riba-Llena, I. et al. Small cortical infarcts: prevalence, determinants, and cognitive correlates in the general population. Int. J. Stroke. 10 Suppl A100, 18\u201324 (2015).","journal-title":"Int. J. Stroke"},{"key":"69989_CR33","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/jcbfm.2015.121","volume":"36","author":"HMA Abraham","year":"2016","unstructured":"Abraham, H. M. A. et al. Cardiovascular risk factors and small vessel disease of the brain: Blood pressure, white matter lesions, and functional decline in older persons. J. Cereb. Blood Flow. Metab. 36, 132\u2013142 (2016).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"69989_CR34","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1212\/WNL.54.9.1795","volume":"54","author":"FE de Leeuw","year":"2000","unstructured":"de Leeuw, F. E. et al. Atrial fibrillation and the risk of cerebral white matter lesions. Neurology 54, 1795\u20131801 (2000).","journal-title":"Neurology"},{"key":"69989_CR35","doi-asserted-by":"publisher","unstructured":"Guerreiro, R. et al. A comprehensive assessment of benign genetic variability for neurodegenerative disorders. bioRxiv 270686 https:\/\/doi.org\/10.1101\/270686 (2018).","DOI":"10.1101\/270686"},{"key":"69989_CR36","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1002\/mds.28510","volume":"36","author":"SH Jeong","year":"2021","unstructured":"Jeong, S. H. et al. White Matter Hyperintensities, Dopamine Loss, and Motor Deficits in De Novo Parkinson\u2019s Disease. Mov. Disord. 36, 1411\u20131419 (2021).","journal-title":"Mov. Disord"},{"key":"69989_CR37","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.neurobiolaging.2022.11.013","volume":"123","author":"M Foddis","year":"2023","unstructured":"Foddis, M. et al. TREX1 p.A129fs and p.Y305C variants in a large multi-ethnic cohort of CADASIL-like unrelated patients. Neurobiol. Aging. 123, 208\u2013215 (2023).","journal-title":"Neurobiol. Aging"},{"key":"69989_CR38","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1093\/bioinformatics\/btu314","volume":"30","author":"GG Faust","year":"2014","unstructured":"Faust, G. G. & Hall, I. M. SAMBLASTER: fast duplicate marking and structural variant read extraction. Bioinformatics 30, 2503\u20132505 (2014).","journal-title":"Bioinformatics"},{"key":"69989_CR39","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ng.806","volume":"43","author":"MA DePristo","year":"2011","unstructured":"DePristo, M. A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 43, 491\u2013498 (2011).","journal-title":"Nat. Genet."},{"key":"69989_CR40","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/humu.22531","volume":"35","author":"M J\u00e4ger","year":"2014","unstructured":"J\u00e4ger, M. et al. Jannovar: a java library for exome annotation. Hum. Mutat. 35, 548\u2013555 (2014).","journal-title":"Hum. Mutat."},{"key":"69989_CR41","doi-asserted-by":"publisher","first-page":"6072","DOI":"10.1038\/s41598-021-84919-x","volume":"11","author":"C Messerschmidt","year":"2021","unstructured":"Messerschmidt, C. et al. PHACTR1 genetic variability is not critical in small vessel ischemic disease patients and PcomA recruitment in C57BL\/6J mice. Sci. Rep. 11, 6072 (2021).","journal-title":"Sci. Rep."},{"key":"69989_CR42","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405\u2013424 (2015).","journal-title":"Genet. Med."},{"key":"69989_CR43","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1007\/s00415-023-11594-5","volume":"270","author":"Y Qin","year":"2023","unstructured":"Qin, Y. et al. Neuroimaging uncovers distinct relationships of glymphatic dysfunction and motor symptoms in Parkinson\u2019s disease. J. Neurol. 270, 2649\u20132658 (2023).","journal-title":"J. Neurol."},{"key":"69989_CR44","doi-asserted-by":"publisher","first-page":"e1851","DOI":"10.1212\/WNL.0000000000006503","volume":"91","author":"C Groot","year":"2018","unstructured":"Groot, C. et al. Clinical phenotype, atrophy, and small vessel disease in APOE\u03b52 carriers with Alzheimer disease. Neurology 91, e1851\u2013e1859 (2018).","journal-title":"Neurology"},{"key":"69989_CR45","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/jcbfm.2015.85","volume":"36","author":"B Gesierich","year":"2016","unstructured":"Gesierich, B. et al. APOE \u025b2 is associated with white matter hyperintensity volume in CADASIL. J. Cereb. Blood Flow. Metab. 36, 199\u2013203 (2016).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"69989_CR46","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/ana.21039","volume":"61","author":"DM Kay","year":"2007","unstructured":"Kay, D. M. et al. Heterozygous parkin point mutations are as common in control subjects as in Parkinson\u2019s patients. Ann. Neurol. 61, 47\u201354 (2007).","journal-title":"Ann. Neurol."},{"key":"69989_CR47","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1093\/brain\/awz191","volume":"142","author":"MMX Tan","year":"2019","unstructured":"Tan, M. M. X. et al. Genetic analysis of Mendelian mutations in a large UK population-based Parkinson\u2019s disease study. Brain 142, 2828\u20132844 (2019).","journal-title":"Brain"},{"key":"69989_CR48","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s11682-021-00522-8","volume":"16","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Altered microstructural properties of superficial white matter in patients with Parkinson\u2019s disease. Brain Imaging Behav. 16, 476\u2013491 (2022).","journal-title":"Brain Imaging Behav."},{"key":"69989_CR49","doi-asserted-by":"publisher","first-page":"1439443","DOI":"10.3389\/fnins.2024.1439443","volume":"18","author":"X Yuan","year":"2024","unstructured":"Yuan, X. et al. Microstructural alterations in white matter and related neurobiology based on the new clinical subtypes of Parkinson\u2019s disease. Front. Neurosci. 18, 1439443 (2024).","journal-title":"Front. Neurosci."},{"key":"69989_CR50","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3174\/ajnr.A0850","volume":"29","author":"AT Karagulle Kendi","year":"2008","unstructured":"Karagulle Kendi, A. T., Lehericy, S., Luciana, M., Ugurbil, K. & Tuite, P. Altered diffusion in the frontal lobe in Parkinson disease. AJNR Am. J. Neuroradiol. 29, 501\u2013505 (2008).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"69989_CR51","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/jnnp.2003.021873","volume":"75","author":"K Yoshikawa","year":"2004","unstructured":"Yoshikawa, K., Nakata, Y., Yamada, K. & Nakagawa, M. Early pathological changes in the parkinsonian brain demonstrated by diffusion tensor MRI. J. Neurol. Neurosurg. Psychiatry. 75, 481\u2013484 (2004).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"69989_CR52","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/nan.12677","volume":"47","author":"D Kirschenbaum","year":"2021","unstructured":"Kirschenbaum, D. et al. Intracerebral endotheliitis and microbleeds are neuropathological features of COVID-19. Neuropathol. Appl. Neurobiol. 47, 454\u2013459 (2021).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"69989_CR53","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1007\/s00415-019-09253-9","volume":"266","author":"S St\u00f6sser","year":"2019","unstructured":"St\u00f6sser, S., B\u00f6ckler, S., Ludolph, A. C., Kassubek, J. & Neugebauer, H. Juxtacortical lesions are associated with seizures in cerebral small vessel disease. J. Neurol. 266, 1230\u20131235 (2019).","journal-title":"J. Neurol."},{"key":"69989_CR54","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1093\/brain\/awae073","volume":"147","author":"MJ Kmiecik","year":"2024","unstructured":"Kmiecik, M. J. et al. Genetic analysis and natural history of Parkinson\u2019s disease due to the LRRK2 G2019S variant. Brain 147, 1996\u20132008 (2024).","journal-title":"Brain"},{"key":"69989_CR55","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1002\/mds.28189","volume":"35","author":"M San Luciano","year":"2020","unstructured":"San Luciano, M. et al. Nonsteroidal Anti-inflammatory Use and LRRK2 Parkinson\u2019s Disease Penetrance. Mov. Disord. 35, 1755\u20131764 (2020).","journal-title":"Mov. Disord"},{"key":"69989_CR56","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/ana.24647","volume":"79","author":"S Lee","year":"2016","unstructured":"Lee, S. et al. White matter hyperintensities are a core feature of Alzheimer\u2019s disease: Evidence from the dominantly inherited Alzheimer network. Ann. Neurol. 79, 929\u2013939 (2016).","journal-title":"Ann. Neurol."},{"key":"69989_CR57","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1007\/s12035-023-03212-2","volume":"60","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Interaction Between the Glymphatic System and \u03b1-Synuclein in Parkinson\u2019s Disease. Mol. Neurobiol. 60, 2209\u20132222 (2023).","journal-title":"Mol. Neurobiol."},{"key":"69989_CR58","doi-asserted-by":"publisher","first-page":"137995","DOI":"10.1016\/j.neulet.2024.137995","volume":"842","author":"M Ota","year":"2024","unstructured":"Ota, M. et al. Relationships between neuroimaging biomarkers and glymphatic-system activity in dementia with Lewy bodies. Neurosci. Lett. 842, 137995 (2024).","journal-title":"Neurosci. Lett."},{"key":"69989_CR59","doi-asserted-by":"publisher","first-page":"e2880","DOI":"10.1002\/brb3.2880","volume":"13","author":"K Chen","year":"2023","unstructured":"Chen, K. et al. Lacunes may worsen cognition but not motor function in Parkinson\u2019s disease. Brain Behav. 13, e2880 (2023).","journal-title":"Brain Behav."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-69989-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-69989-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-69989-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:04:21Z","timestamp":1790089461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-69989-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["69989"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-69989-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original \t\t\t\t online version of this Article was revised: In the original version of this Article the ORCID ID for Celeste Sassi was inadvertently omitted. The ORCID ID for Celeste Sassi is 0000-0002-2837-1765.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"28063"}}